StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · AZTA·Healthcare

Azenta, Inc. Stock Analysis & AI Score

Azenta, Inc. (AZTA) has an ST Score of 48.5 (C+), driven by its Momentum (A-) and held back by its Profitability (D-). Analysts rate it Buy with a $43.00 price target (+25.7% upside).

Market Closed
$34.20
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
49
ST Score
48.5/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

AZTA
48.5out of 100
Grade C+

Azenta, Inc. (AZTA) has an ST Score of 48.5 (C+), driven by its Momentum (A-) and held back by its Profitability (D-). Analysts rate it Buy with a $43.00 price target (+25.7% upside).

Strongest
MomentumA-
Weakest
ProfitabilityD-
All factor grades
  • MomentumA-
  • ValuationB-
  • Financial StrengthB-
  • ForecastB-
  • GrowthC+
  • ProfitabilityD-
  • Piotroski4/9
Score methodology
Press Releases

Contact

AZTA stock: frequently asked questions

What is AZTA's ST Score?

Azenta, Inc. (AZTA) has an ST Score of 48.5 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is AZTA a buy, hold, or sell?

Analysts rate AZTA a Buy, with a price target of $43.00 (+25.7% vs the current price). Our ST Score grades it C+ (48.5/100). The ST Score is a data-driven signal, not a recommendation.

What are AZTA's factor grades?

Valuation B-, Profitability D-, Financial Strength B-, Momentum A-, Growth C+, Forecast B-.

What is AZTA's valuation grade?

Azenta, Inc. (AZTA) earns a valuation grade of B-, measured against Medical - Instruments & Supplies peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is AZTA's growth grade?

Azenta, Inc. (AZTA) earns a growth grade of C+, measured against Medical - Instruments & Supplies peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is AZTA's profitability grade?

Azenta, Inc. (AZTA) earns a profitability grade of D-, measured against Medical - Instruments & Supplies peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is AZTA's financial strength grade?

Azenta, Inc. (AZTA) earns a financial strength grade of B-, measured against Medical - Instruments & Supplies peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for AZTA?

The average analyst price target for Azenta, Inc. (AZTA) is $43.00 from 12 analysts, which is +25.7% versus the recent price of $34.20.

What is AZTA's Piotroski score?

Azenta, Inc. (AZTA) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.